MU
46
6
NAVI
35
5
ADBE
44
3
DVA
67
6
EQT
47
2
KLAC
59
3
AKAM
43
8
NI
65
-2
APD
54
4
CMG
54
3
CMS
67
2
FOXA
59
2
BF.B
59
2
GD
55
3
FITB
45
2
HON
58
3
GS
46
-2
NKE
42
2
KMI
51
-4
DIS
70
10
MU
46
6
NAVI
35
5
ADBE
44
3
DVA
67
6
EQT
47
2
KLAC
59
3
AKAM
43
8
NI
65
-2
APD
54
4
CMG
54
3
CMS
67
2
FOXA
59
2
BF.B
59
2
GD
55
3
FITB
45
2
HON
58
3
GS
46
-2
NKE
42
2
KMI
51
-4
DIS
70
10
Financhill
Back

AstraZeneca PLC 10K Form

Buy
62

AZNCF
AstraZeneca PLC

Last Price:
$149.25
Seasonality Move:
9.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AZNCF News And Ratings

See the #1 stock for the next 7 days that we like better than AZNCF

AZNCF Financial Statistics

Sales & Book Value

Annual Sales: $54.1B
Cash Flow: $2B
Price / Cash Flow: 32.02
Annual Sales: $26.30
Price / Book: 5.68

Profitability

EPS (TTM): 4.51000
Net Income (TTM): $7B
Gross Margin: $43.9B
Return on Equity: 17.77%
Return on Assets: 6.77%

AstraZeneca PLC Earnings Forecast

Key AstraZeneca PLC Financial Ratios

  • The Gross Profit Margin over the past 27 years for AZNCF is 81.12%.
  • The Selling, General & Administrative Expenses for AZNCF have been equal to 37.40% of Gross Profit Margin.
  • The Research & Development expenses have been 25.12% of Revenue.
  • The Interest Expense is 23.91% of Operating Income.
  • The Net Earning history of AZNCF is 13.01% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 21 years.

AstraZeneca PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AZNCF
Website: astrazeneca.com

Debt

Debt-to-Equity Ratio: 0.7
Current Ratio: 0.93
Quick Ratio: 0.74

Price-to-Earnings

Trailing P/E Ratio: 33.17
Forward P/E Ratio: 0

AZNCF Technical Analysis vs Fundamental Analysis

Buy
62
AstraZeneca PLC (AZNCF) is a Buy

Is AstraZeneca PLC a Buy or a Sell?

  • AstraZeneca PLC stock is rated a Buy
    The current AstraZeneca PLC [AZNCF] share price is $149.25. The Score for AZNCF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.